Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1.08
MDSO's Cash to Debt is ranked lower than
75% of the 1778 Companies
in the Global Health Information Services industry.

( Industry Median: 20.37 vs. MDSO: 1.08 )
Ranked among companies with meaningful Cash to Debt only.
MDSO' s 10-Year Cash to Debt Range
Min: 0.4  Med: 94.18 Max: N/A
Current: 1.08
Equity to Asset 0.43
MDSO's Equity to Asset is ranked lower than
77% of the 1576 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. MDSO: 0.43 )
Ranked among companies with meaningful Equity to Asset only.
MDSO' s 10-Year Equity to Asset Range
Min: -1.75  Med: 0.41 Max: 0.67
Current: 0.43
-1.75
0.67
Interest Coverage 1.31
MDSO's Interest Coverage is ranked lower than
96% of the 1162 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDSO: 1.31 )
Ranked among companies with meaningful Interest Coverage only.
MDSO' s 10-Year Interest Coverage Range
Min: 1.31  Med: 98.34 Max: 9999.99
Current: 1.31
1.31
9999.99
F-Score: 5
Z-Score: 5.49
M-Score: -2.55
WACC vs ROIC
14.70%
35.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 5.77
MDSO's Operating margin (%) is ranked higher than
53% of the 1743 Companies
in the Global Health Information Services industry.

( Industry Median: 5.11 vs. MDSO: 5.77 )
Ranked among companies with meaningful Operating margin (%) only.
MDSO' s 10-Year Operating margin (%) Range
Min: -36.17  Med: 7.44 Max: 14
Current: 5.77
-36.17
14
Net-margin (%) 1.99
MDSO's Net-margin (%) is ranked lower than
56% of the 1743 Companies
in the Global Health Information Services industry.

( Industry Median: 3.23 vs. MDSO: 1.99 )
Ranked among companies with meaningful Net-margin (%) only.
MDSO' s 10-Year Net-margin (%) Range
Min: -52.41  Med: 3.69 Max: 21.36
Current: 1.99
-52.41
21.36
ROE (%) 2.78
MDSO's ROE (%) is ranked lower than
59% of the 1705 Companies
in the Global Health Information Services industry.

( Industry Median: 6.32 vs. MDSO: 2.78 )
Ranked among companies with meaningful ROE (%) only.
MDSO' s 10-Year ROE (%) Range
Min: 2.48  Med: 14.64 Max: 63.95
Current: 2.78
2.48
63.95
ROA (%) 1.18
MDSO's ROA (%) is ranked lower than
58% of the 1786 Companies
in the Global Health Information Services industry.

( Industry Median: 3.26 vs. MDSO: 1.18 )
Ranked among companies with meaningful ROA (%) only.
MDSO' s 10-Year ROA (%) Range
Min: -106.4  Med: 4.46 Max: 22.66
Current: 1.18
-106.4
22.66
ROC (Joel Greenblatt) (%) 57.24
MDSO's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 1757 Companies
in the Global Health Information Services industry.

( Industry Median: 24.49 vs. MDSO: 57.24 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MDSO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -318.3  Med: 80.52 Max: 277.92
Current: 57.24
-318.3
277.92
Revenue Growth (3Y)(%) 17.50
MDSO's Revenue Growth (3Y)(%) is ranked higher than
82% of the 1314 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. MDSO: 17.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MDSO' s 10-Year Revenue Growth (3Y)(%) Range
Min: -21.7  Med: 6.90 Max: 17.5
Current: 17.5
-21.7
17.5
EBITDA Growth (3Y)(%) -2.70
MDSO's EBITDA Growth (3Y)(%) is ranked lower than
65% of the 1050 Companies
in the Global Health Information Services industry.

( Industry Median: 6.70 vs. MDSO: -2.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MDSO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -4.15 Max: 14.7
Current: -2.7
0
14.7
EPS Growth (3Y)(%) -48.40
MDSO's EPS Growth (3Y)(%) is ranked lower than
91% of the 973 Companies
in the Global Health Information Services industry.

( Industry Median: 6.50 vs. MDSO: -48.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MDSO' s 10-Year EPS Growth (3Y)(%) Range
Min: -48.4  Med: -13.00 Max: 42.9
Current: -48.4
-48.4
42.9
» MDSO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MDSO Guru Trades in Q3 2014

Columbia Wanger 1,793,500 sh (+31.83%)
Frank Sands 4,866,217 sh (+3.10%)
Chuck Royce 40,000 sh (unchged)
Steven Cohen Sold Out
Ron Baron 193,346 sh (-16.17%)
George Soros 6,666 sh (-94.74%)
» More
Q4 2014

MDSO Guru Trades in Q4 2014

Jim Simons 5,494 sh (New)
Columbia Wanger 1,999,800 sh (+11.50%)
Frank Sands 5,126,077 sh (+5.34%)
Frank Sands 5,126,077 sh (+5.34%)
Chuck Royce 40,000 sh (unchged)
George Soros Sold Out
Ron Baron 189,579 sh (-1.95%)
» More
Q1 2015

MDSO Guru Trades in Q1 2015

Joel Greenblatt 19,844 sh (New)
Chuck Royce 166,765 sh (+316.91%)
Frank Sands 5,399,777 sh (+5.34%)
Columbia Wanger 2,008,800 sh (+0.45%)
Jim Simons Sold Out
Ron Baron 147,353 sh (-22.27%)
» More
Q2 2015

MDSO Guru Trades in Q2 2015

Paul Tudor Jones 4,672 sh (New)
Jim Simons 16,294 sh (New)
Frank Sands 5,576,577 sh (+3.27%)
Frank Sands 5,576,577 sh (+3.27%)
Joel Greenblatt Sold Out
Columbia Wanger 1,945,061 sh (-3.17%)
Chuck Royce 160,465 sh (-3.78%)
Ron Baron 122,944 sh (-16.56%)
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 372.07
MDSO's P/E(ttm) is ranked lower than
97% of the 1122 Companies
in the Global Health Information Services industry.

( Industry Median: 24.44 vs. MDSO: 372.07 )
Ranked among companies with meaningful P/E(ttm) only.
MDSO' s 10-Year P/E(ttm) Range
Min: 11.44  Med: 67.48 Max: 2448.5
Current: 372.07
11.44
2448.5
Forward P/E 47.17
MDSO's Forward P/E is ranked lower than
81% of the 553 Companies
in the Global Health Information Services industry.

( Industry Median: 19.23 vs. MDSO: 47.17 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 385.30
MDSO's PE(NRI) is ranked lower than
97% of the 1094 Companies
in the Global Health Information Services industry.

( Industry Median: 23.70 vs. MDSO: 385.30 )
Ranked among companies with meaningful PE(NRI) only.
MDSO' s 10-Year PE(NRI) Range
Min: 11.53  Med: 63.56 Max: 2448.5
Current: 385.3
11.53
2448.5
P/B 9.16
MDSO's P/B is ranked lower than
87% of the 1654 Companies
in the Global Health Information Services industry.

( Industry Median: 2.67 vs. MDSO: 9.16 )
Ranked among companies with meaningful P/B only.
MDSO' s 10-Year P/B Range
Min: 4.53  Med: 10.41 Max: 28.83
Current: 9.16
4.53
28.83
P/S 7.27
MDSO's P/S is ranked lower than
83% of the 1797 Companies
in the Global Health Information Services industry.

( Industry Median: 2.14 vs. MDSO: 7.27 )
Ranked among companies with meaningful P/S only.
MDSO' s 10-Year P/S Range
Min: 1.31  Med: 4.08 Max: 12.62
Current: 7.27
1.31
12.62
PFCF 42.15
MDSO's PFCF is ranked lower than
73% of the 838 Companies
in the Global Health Information Services industry.

( Industry Median: 23.98 vs. MDSO: 42.15 )
Ranked among companies with meaningful PFCF only.
MDSO' s 10-Year PFCF Range
Min: 12.91  Med: 53.88 Max: 276.85
Current: 42.15
12.91
276.85
POCF 36.64
MDSO's POCF is ranked lower than
78% of the 1045 Companies
in the Global Health Information Services industry.

( Industry Median: 17.66 vs. MDSO: 36.64 )
Ranked among companies with meaningful POCF only.
MDSO' s 10-Year POCF Range
Min: 10.42  Med: 38.77 Max: 133.3
Current: 36.64
10.42
133.3
EV-to-EBIT 112.80
MDSO's EV-to-EBIT is ranked lower than
90% of the 1175 Companies
in the Global Health Information Services industry.

( Industry Median: 16.64 vs. MDSO: 112.80 )
Ranked among companies with meaningful EV-to-EBIT only.
MDSO' s 10-Year EV-to-EBIT Range
Min: 8.8  Med: 44.40 Max: 381.8
Current: 112.8
8.8
381.8
PEG 202.79
MDSO's PEG is ranked lower than
100% of the 485 Companies
in the Global Health Information Services industry.

( Industry Median: 1.74 vs. MDSO: 202.79 )
Ranked among companies with meaningful PEG only.
MDSO' s 10-Year PEG Range
Min: 7.91  Med: 42.04 Max: 209.64
Current: 202.79
7.91
209.64
Shiller P/E 115.92
MDSO's Shiller P/E is ranked lower than
90% of the 697 Companies
in the Global Health Information Services industry.

( Industry Median: 28.81 vs. MDSO: 115.92 )
Ranked among companies with meaningful Shiller P/E only.
MDSO' s 10-Year Shiller P/E Range
Min: 110.05  Med: 150.87 Max: 6000
Current: 115.92
110.05
6000
Current Ratio 3.32
MDSO's Current Ratio is ranked higher than
73% of the 1621 Companies
in the Global Health Information Services industry.

( Industry Median: 2.07 vs. MDSO: 3.32 )
Ranked among companies with meaningful Current Ratio only.
MDSO' s 10-Year Current Ratio Range
Min: 0.44  Med: 2.15 Max: 5.35
Current: 3.32
0.44
5.35
Quick Ratio 3.32
MDSO's Quick Ratio is ranked higher than
74% of the 1621 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. MDSO: 3.32 )
Ranked among companies with meaningful Quick Ratio only.
MDSO' s 10-Year Quick Ratio Range
Min: 0.44  Med: 2.15 Max: 5.35
Current: 3.32
0.44
5.35
Days Sales Outstanding 93.32
MDSO's Days Sales Outstanding is ranked lower than
70% of the 1505 Companies
in the Global Health Information Services industry.

( Industry Median: 68.76 vs. MDSO: 93.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDSO' s 10-Year Days Sales Outstanding Range
Min: 45.45  Med: 72.70 Max: 90.9
Current: 93.32
45.45
90.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 9.82
MDSO's Price/Tangible Book is ranked lower than
78% of the 1363 Companies
in the Global Health Information Services industry.

( Industry Median: 3.91 vs. MDSO: 9.82 )
Ranked among companies with meaningful Price/Tangible Book only.
MDSO' s 10-Year Price/Tangible Book Range
Min: 6.32  Med: 11.18 Max: 151.5
Current: 9.82
6.32
151.5
Price/Projected FCF 4.83
MDSO's Price/Projected FCF is ranked lower than
83% of the 820 Companies
in the Global Health Information Services industry.

( Industry Median: 1.67 vs. MDSO: 4.83 )
Ranked among companies with meaningful Price/Projected FCF only.
MDSO' s 10-Year Price/Projected FCF Range
Min: 4.95  Med: 6.75 Max: 10.1
Current: 4.83
4.95
10.1
Price/Median PS Value 1.78
MDSO's Price/Median PS Value is ranked lower than
81% of the 1548 Companies
in the Global Health Information Services industry.

( Industry Median: 1.12 vs. MDSO: 1.78 )
Ranked among companies with meaningful Price/Median PS Value only.
MDSO' s 10-Year Price/Median PS Value Range
Min: 0.33  Med: 1.01 Max: 2.92
Current: 1.78
0.33
2.92
Price/Graham Number 12.57
MDSO's Price/Graham Number is ranked lower than
95% of the 880 Companies
in the Global Health Information Services industry.

( Industry Median: 2.11 vs. MDSO: 12.57 )
Ranked among companies with meaningful Price/Graham Number only.
MDSO' s 10-Year Price/Graham Number Range
Min: 1.91  Med: 7.37 Max: 29.93
Current: 12.57
1.91
29.93
Earnings Yield (Greenblatt) (%) 0.85
MDSO's Earnings Yield (Greenblatt) (%) is ranked lower than
60% of the 1771 Companies
in the Global Health Information Services industry.

( Industry Median: 2.60 vs. MDSO: 0.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDSO' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.3  Med: 2.25 Max: 11.3
Current: 0.85
0.3
11.3
Forward Rate of Return (Yacktman) (%) -4.85
MDSO's Forward Rate of Return (Yacktman) (%) is ranked lower than
80% of the 693 Companies
in the Global Health Information Services industry.

( Industry Median: 10.77 vs. MDSO: -4.85 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDSO' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -5  Med: 0.90 Max: 21.2
Current: -4.85
-5
21.2

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 403 481 553
EPS($) 0.61 1.01 1.16
EPS without NRI($) 0.61 1.01 1.16

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:2M9.Germany,
Medidata Solutions Inc was incorporated in June 1999and reincorporated in the State of Delaware in May 2000. The Company is a provider of cloud-based solutions for clinical research in life sciences, designed to transform clinical development and increase the value of the customers' research investments. Medidata's solutions are designed to address the underlying requirements of clinical development, rather than just its current processes, to maximize the value of the overall research process. Its cloud-based solutions, metrics and services allow users to accurately and efficiently design clinical trials; manage and monitor ongoing trial activities; develop and administer trial budgets; capture, manage and report clinical trial data; plan and execute randomized subject allocation methodologies; manage and allocate clinical trial supplies; and view, track, and evaluate trial progress through easy-to-use, Internet-enabled platforms. The Company compete with firms such as Oracle, Perceptive Informatics and others offering products and services that compete with one or more of the solutions. It competes on the basis of several factors, including, breadth and depth of solution offerings; platform capabilities, including interoperability; ease of use of solutions and rates of user adoption; solution functionality and flexibility; analytics and benchmarking; speed and performance required to enable customers to access clinical trial data in real-time; product reliability and scalability; infrastructure accessibility and security; regulatory compliance; financial stability; commercial and technology partnerships; depth of expertise and quality of professional services and customer support on a global basis; and sales and marketing capabilities, including the ability to create and communicate operational value. The Company has registered trademarks and service marks in the United States and abroad, and filed applications for the registration of additional trademarks and service marks. The principal trademarks are "Medidata," "Medidata Clinical Cloud," "Medidata Patient Cloud," "Medidata CRO Contractor," "Medidata Designer," "Medidata Grants Manager," "Medidata Rave," "Medidata Balance," "Medidata Coder," and "Medidata Insights." It also holds several domain names, including the domain names "mdsol.com" and "medidatasolutions.com". The use of Company's software products, services and hosted solutions by customers engaged in clinical trials must be done in a manner that is compliant with a complex array of United States federal and state laws and regulations, including regulation by the Food and Drug Administration, as well as regulations and guidance issued by foreign governments and international non-governmental organizations.
» More Articles for MDSO

Headlines

Articles On GuruFocus.com
There’s More In The Clouds At Medidata Than Just The Valuation Jul 21 2015 
Frank Sands Adds to His Position in Medidata Solutions, Inc. Jul 14 2015 
Medidata: SaaS Business Model Leveraging Growth Of The Company Oct 23 2014 
Frank Sands Adds 5 New Stocks Aug 14 2014 
Medidata Solutions: Benefit from Growing Cloud Applications with This Stock May 27 2014 
Medidata Solutions : A SAAS Provider For Your Portfolio Mar 23 2014 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares Mar 08 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,000 Shares Mar 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Feb 07 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Feb 03 2011 

More From Other Websites
Medidata's Cloud-Based Platform Powers Next-Generation Immunotherapy Vaccine Trial in Australia Aug 26 2015
Medidata’s Cloud-Based Platform Powers Next-Generation Immunotherapy Vaccine Trial in Australia Aug 26 2015
MEDIDATA SOLUTIONS, INC. Financials Aug 20 2015
10-Q for Medidata Solutions, Inc. Aug 13 2015
CGI Group, Inc. Earnings Q2*, 2015 Aug 06 2015
Medidata Leaders Honored Among PharmaVOICE 100 Most Inspiring People Aug 03 2015
Medidata Leaders Honored Among PharmaVOICE 100 Most Inspiring People Aug 03 2015
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jul 27 2015
Medidata Misses Q2 Earnings Estimates, Beats Revenues - Analyst Blog Jul 23 2015
Stocks Weaken Near Midday; Medidata's Breakout Fails Jul 21 2015
Edited Transcript of MDSO earnings conference call or presentation 21-Jul-15 12:00pm GMT Jul 21 2015
Medidata Solutions Inc Earnings Call scheduled for 8:00 am ET today Jul 21 2015
Q2 2015 Medidata Solutions Inc Earnings Release - Before Market Open Jul 21 2015
Medidata and Validic Integrate Cloud Technology Platforms, Expanding Mobile Health Ecosystem to... Jul 21 2015
Medidata and Validic Integrate Cloud Technology Platforms, Expanding Mobile Health Ecosystem to... Jul 21 2015
Medidata Reports Record Second Quarter 2015 Revenues Jul 21 2015
Medidata tops Street 2Q forecasts Jul 21 2015
Medidata tops Street 2Q forecasts Jul 21 2015
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 21 2015
Medidata Reports Record Second Quarter 2015 Revenues Jul 21 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK